Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baruchel

Showing results (131-140 of 590) with videos related to

Pageof 59
Sort By:
BMC Cancer|June 30, 2006
Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg) in children with relapsed/refractory myeloid leukemiaBenoit Brethon, Anne Auvrignon, Claire Galambrun, et al.
Bone Marrow Transplantation|July 28, 2009
Cellular immune parameters associated with spontaneous control of CMV in children who underwent transplantationV Guérin, J-H Dalle, B Pédron, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|November 5, 1997
[Imerslund's disease. Clinical and biological aspects. Apropos of 6 cases]O Flechelles, P Schneider, J F Lesesve, et al.
Leukemia|October 1, 1994
Translocation t(11;11)(q13;q23) and HRX gene rearrangement associated with therapy-related leukemia in a child previously treated with VP16T Leblanc, J Hillion, J Derré, et al.
Bone Marrow Transplantation|August 1, 2006
Final height and gonad function after total body irradiation during childhoodA-C Couto-Silva, C Trivin, H Esperou, et al.
Hematology and Cell Therapy|April 1, 1997
Chronic myelomonocytic leukemia: from biology to therapyN Cambier, A Baruchel, M H Schlageter, et al.
Cytokines, Cellular & Molecular Therapy|June 1, 1997
G-CSF activates STAT pathways in Kasumi-1 myeloid leukemic cells with the t(8; 21) translocation: basis for potential therapeutic efficacyN Da Silva, S Meyer-Monard, M L Menot, et al.
Pediatrics|May 9, 2007
Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trialElena Pope, Bernice R Krafchik, Colin Macarthur, et al.
Children (Basel, Switzerland)|March 6, 2021
Variability of Prognostic Results Based on Biological Parameters in Sickle Cell Disease Cohort Studies in Children: What Should Clinicians Know?Julie Sommet, Enora Le Roux, Bérengère Koehl, et al.
Cancer|September 11, 2001
Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin, and etoposide chemotherapy in children with refractory carcinomaM Fouladi, D Stempak, J Gammon, et al.
Pageof 59

Showing results (131-140 of 590) with videos related to

Sort By:
Pageof 59
BMC Cancer|June 30, 2006
Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg) in children with relapsed/refractory myeloid leukemiaBenoit Brethon, Anne Auvrignon, Claire Galambrun, et al.
Bone Marrow Transplantation|July 28, 2009
Cellular immune parameters associated with spontaneous control of CMV in children who underwent transplantationV Guérin, J-H Dalle, B Pédron, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|November 5, 1997
[Imerslund's disease. Clinical and biological aspects. Apropos of 6 cases]O Flechelles, P Schneider, J F Lesesve, et al.
Leukemia|October 1, 1994
Translocation t(11;11)(q13;q23) and HRX gene rearrangement associated with therapy-related leukemia in a child previously treated with VP16T Leblanc, J Hillion, J Derré, et al.
Bone Marrow Transplantation|August 1, 2006
Final height and gonad function after total body irradiation during childhoodA-C Couto-Silva, C Trivin, H Esperou, et al.
Hematology and Cell Therapy|April 1, 1997
Chronic myelomonocytic leukemia: from biology to therapyN Cambier, A Baruchel, M H Schlageter, et al.
Cytokines, Cellular & Molecular Therapy|June 1, 1997
G-CSF activates STAT pathways in Kasumi-1 myeloid leukemic cells with the t(8; 21) translocation: basis for potential therapeutic efficacyN Da Silva, S Meyer-Monard, M L Menot, et al.
Pediatrics|May 9, 2007
Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trialElena Pope, Bernice R Krafchik, Colin Macarthur, et al.
Children (Basel, Switzerland)|March 6, 2021
Variability of Prognostic Results Based on Biological Parameters in Sickle Cell Disease Cohort Studies in Children: What Should Clinicians Know?Julie Sommet, Enora Le Roux, Bérengère Koehl, et al.
Cancer|September 11, 2001
Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin, and etoposide chemotherapy in children with refractory carcinomaM Fouladi, D Stempak, J Gammon, et al.
Pageof 59